Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Roberts to market Lodine in U.K. and Ireland

Jan. 8, 1997

Neurobiological Technologies discontinues development of antiarthritic agent

Jan. 8, 1997

Anti-gp130 MAbs for inflammatory disorders and myeloma

Jan. 2, 1997

British researchers describe anticytokine antisense peptides

Dec. 30, 1996

Biomatrix-Boehringer Ingelheim Synvisc agreement

Dec. 23, 1996

ConXn effective in lung fibrosis

Dec. 20, 1996

GLA effective in treating active rheumatoid arthritis

Dec. 18, 1996

Anti-L-selectin aptamers demonstrate efficacy in animals

Dec. 18, 1996

ML-3000 progresses through the pipeline

Dec. 18, 1996

Antiinflammatory glycolipid compounds from Nissin Food Products

Dec. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...